2011
| Fusion Inhibitor | ||
| Common Name | Brand Name | Manufacturer |
| T-20, enfuvirtide | Fuzeon | Roche |
| Co-Receptor Inhibitor | ||
| Common Name | Brand Name | Manufacturer |
| maraviroc | Celsentri | ViiV Healthcare (formerly Pfizer) |
| Nukes (Nucleoside and Nucleotide Analogues, or NRTIs) | ||
| Common Name | Brand Name | Manufacturer |
| abacavir, ABC | Ziagen | ViiV Healthcare (formerly GlaxoSmithKline) |
| AZT, zidovudine | Retrovir | ViiV Healthcare (formerly GlaxoSmithKline) |
| d4T, stavudine | Zerit | Bristol-Myers Squibb |
| ddI, didanosine | Videx EC (enteric-coated) | Bristol-Myers Squibb |
| FTC, emtricitabine | FTC is only available in Canada co-formulated with tenofovir, as Truvada | Gilead Sciences |
| tenofovir* | Viread | Gilead Sciences |
| 3TC, lamivudine | 3TC | ViiV Healthcare (formerly GlaxoSmithKline-Shire BioChem) |
| Non-Nukes (NNRTIs) | ||
| Common Name | Brand Name | Manufacturer |
| delavirdine | Rescriptor | ViiV Healthcare (formerly Pfizer) |
| efavirenz | Sustiva | Bristol-Myers Squibb |
| etravirine | Intelence | Tibotec |
| nevirapine | Viramune | Boehringer Ingelheim |
| Integrase Inhibitor | ||
| Common Name | Brand Name | Manufacturer |
| raltegravir | Isentress | Merck |
| Protease Inhibitors | ||
| Common Name | Brand Name | Manufacturer |
| atazanavir | Reyataz | Bristol-Myers Squibb |
| darunavir | Prezista | Tibotec |
| fosamprenavir | Telzir | ViiV Healthcare (formerly GlaxoSmithKline) |
| indinavir | Crixivan | Merck |
| lopinavir-ritonavir | Kaletra | Abbott Laboratories |
| nelfinavir | Viracept | ViiV Healthcare (formerly Pfizer) |
| ritonavir | Norvir | Abbott Laboratories |
| saquinavir | Invirase | Hoffmann-La Roche |
| tipranavir | Aptivus | Boehringer Ingelheim |
|
Co-Formulations Co-formulations take two or more different drugs and combine them into a single pill, reducing the number of pills that need to be taken. | ||
| Common Name | Brand Name | Manufacturer |
| Atripla | efavirenz + FTC + tenofovir | Bristol Myers-Squibb/Gilead Sciences |
| Combivir | AZT + 3TC | ViiV Healthcare (formerly GlaxoSmithKline) |
| Kaletra | lopinavir + ritonavir | Abbott Laboratories |
| Kivexa | 3TC + abacavir | ViiV Healthcare (formerly GlaxoSmithKline) |
| Trizivir | AZT + 3TC + abacavir | ViiV Healthcare (formerly GlaxoSmithKline) |
| Truvada | FTC + tenofovir | Gilead Sciences |
| * Strictly speaking, tenofovir (Viread) is not a nucleoside analogue but a very similar molecule called a nucleotide analogue. This is largely a fine technical distinction; in practice, most HIV-positive people and their doctors refer to tenofovir as a nucleoside. | ||